Intervention strategies for symptomatic middle cerebral atherosclerotic stenosis

doi:10.3969/j.issn.1672-6731.2021.01.009

Abstract

Abstract:

Intracranial atherosclerotic stenosis (ICAS) is the most common cause of ischemic stroke among Asian population, and its predilection site is middle cerebral artery. Symptomatic middle cerebral atherosclerotic stenosis (sMCAS) has a high risk of stroke recurrence and needs active interventions, but the choice of intervention strategy is controversial. This article reviews the pathogenesis, clinical manifestations, imaging evaluation and intervention strategies of sMCAS, aiming to provide reference for individual selection of intervention strategies.

Key words: Intracranial arteriosclerosis, Middle cerebral artery, Review

摘要：

颅内动脉粥样硬化性狭窄是亚洲人群缺血性卒中的常见原因，好发于大脑中动脉。症状性大脑中动脉粥样硬化性狭窄（sMCAS）致缺血性卒中的复发风险较高，需积极的干预治疗，但其干预策略的选择存有争议。本文对 sMCAS 的发病机制、临床表现、影像学评估和干预策略进行综述，旨在为个体化选择干预策略提供参考。

关键词: 颅内动脉硬化, 大脑中动脉, 综述

CHEN Ping, LIU Jia-lin, LIN Jia-xing, GUAN Min, QIAO Hong-yu, HUANG Li-an. Intervention strategies for symptomatic middle cerebral atherosclerotic stenosis[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2021, 21(1): 41-45.

陈平, 刘嘉琳, 林嘉星, 关敏, 乔宏宇, 黄立安. 症状性大脑中动脉粥样硬化性狭窄干预策略[J]. 中国现代神经疾病杂志, 2021, 21(1): 41-45.

/ / Recommend / Download Citations

URL: http://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2021.01.009

http://journal11.magtechjournal.com/cjcnn/EN/Y2021/V21/I1/41

References

[1] Teng Z, Peng W, Zhan Q, Zhang X, Liu Q, Chen S, Tian X, Chen L, Brown AJ, Graves MJ, Gillard JH, Lu J. An assessment on the incremental value of high-resolution magnetic resonance imaging to identify culprit plaques in atherosclerotic disease of the middle cerebral artery[J]. Eur Radiol, 2016, 26:2206-2214.
[2] Wang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, Wang Y, Zou X, Leung TW, Cai Y, Bai Q, Wu Y, Wang C, Pan X, Luo B, Wong KS; CICAS Study Group. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China:the Chinese Intracranial Atherosclerosis (CICAS) study[J]. Stroke, 2014, 45:663-669.
[3] Scientific Statement Expert Group of Chinese Stroke Society. Practices for management of symptomatic intracranial and extracranial atherosclerotic aortic stenosis:scientific statement of the Chinese Stroke Society[J]. Zhongguo Zu Zhong Za Zhi, 2017, 27:64-71.[中国卒中学会科学声明专家组.症状性颅内外动脉粥样硬化性大动脉狭窄管理规范——中国卒中学会科学声明[J].中国卒中杂志, 2017, 27:64-71.]
[4] Zhongrong M, Feng L, Shengmao L, Fengshui Z, Hongqi Z, Moli W, Yang H. Natural history and treatment modalities of symptomatic bilateral middle cerebral artery stenosis[J]. Interv Neuroradiol, 2003, 9:31-38.
[5] Kern R, Steinke W, Daffertshofer M, Prager R, Hennerici M. Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease[J]. Neurology, 2005, 65:859-864.
[6] Kang DH, Yoon W. Current opinion on endovascular therapy for emergent large vessel occlusion due to underlying intracranial atherosclerotic stenosis[J]. Korean J Radiol, 2019, 20:739-748.
[7] Yaghi S, Prabhakaran S, Khatri P, Liebeskind DS. Intracranial atherosclerotic disease:mechanisms and therapeutic implications[J]. Stroke, 2019, 50:1286-1293.
[8] Meng Y, Yu K, Zhang L, Liu Y. Cognitive decline in asymptomatic middle cerebral artery stenosis patients with moderate and poor collaterals:a 2-year follow-up study[J]. Med Sci Monit, 2019, 25:4051-4058.
[9] Leng X, Fang H, Pu Y, Zou X, Pan Y, Soo YOY, Xu Y, Wang C, Zhao X, Wang Y, Wang Y, Liebeskind DS, Wong LKS, Leung TW, Liu L. Cortical microinfarcts in patients with middle cerebral artery stenosis[J]. J Stroke Cerebrovasc Dis, 2017, 26:1760-1765.
[10] Feng X, Chan KL, Lan L, Abrigo J, Liu J, Fang H, Xu Y, Soo Y, Leng X, Leung TW. Stroke mechanisms in symptomatic intracranial atherosclerotic disease:classification and clinical implications[J]. Stroke, 2019, 50:2692-2699.
[11] Park H, Baek JH, Kim BM. Endovascular treatment of acute stroke due to intracranial atherosclerotic stenosis-related large vessel occlusion[J]. Front Neurol, 2019, 10:308.
[12] Guan M, Lin J, Huang S, Leng X, Shi C, Qiao H, Wang X, Huang L. High-degree middle cerebral artery stenosis:can advanced 3D DSA-MRI fusion imaging better illustrate plaques and perforators[J]? Clin Neuroradiol, 2020.[Epub ahead of print]
[13] Chung GH, Kwak HS, Hwang SB, Jin GY. High resolution MR imaging in patients with symptomatic middle cerebral artery stenosis[J]. Eur J Radiol, 2012, 81:4069-4074.
[14] Suzuki T, Natori T, Sasaki M, Miyazawa H, Narumi S, Ito K, Kamada A, Yoshida M, Tsuda K, Yoshioka K, Terayama Y. Evaluating recanalization of relevant lenticulostriate arteries in acute ischemic stroke using high-resolution MRA at 7T[J]. Int J Stroke, 2020.[Epub ahead of print]
[15] Sallustio F, Motta C, Pizzuto S, Diomedi M, Rizzato B, Panella M, Alemseged F, Stefanini M, Fabiano S, Gandini R, Floris R, Stanzione P, Koch G. CT angiography ASPECTS predicts outcome much better than noncontrast CT in patients with stroke treated endovascularly[J]. AJNR Am J Neuroradiol, 2017, 38:1569-1573.
[16] Lou X, Ma X, Liebeskind DS, Ma N, Tian C, Lyu J, Long X, Ma L, Wang DJ. Collateral perfusion using arterial spin labeling in symptomatic versus asymptomatic middle cerebral artery stenosis[J]. J Cereb Blood Flow Metab, 2019, 39:108-117.
[17] Naritomi H, Sawada T, Kuriyama Y, Kinugawa H, Kaneko T, Takamiya M. Effect of chronic middle cerebral artery stenosis on the local cerebral hemodynamics[J]. Stroke, 1985, 16:214-219.
[18] Fang H, Leng X, Pu Y, Zou X, Pan Y, Song B, Soo YOY, Leung TWH, Wang C, Zhao X, Wang Y, Wang Y, Wong KS, Liu L, Xu Y; CICAS Study Group. Hemodynamic significance of middle cerebral artery stenosis associated with the severity of ipsilateral white matter changes[J]. Front Neurol, 2020, 11:214.
[19] Leng X, Lan L, Ip HL, Fan F, Ma SH, Ma K, Liu H, Yan Z, Liu J, Abrigo J, Soo YOY, Liebeskind DS, Wong KS, Leung TW. Translesional pressure gradient and leptomeningeal collateral status in symptomatic middle cerebral artery stenosis[J]. Eur J Neurol, 2018, 25:404-410.
[20] Mori F, Ishida F, Natori T, Miyazawa H, Kameda H, Harada T, Yoshioka K, Yamashita F, Uwano I, Ito K, Sasaki M. Computational fluid dynamics analysis of lateral striate arteries in acute ischemic stroke using 7T high-resolution magnetic resonance angiography[J]. J Stroke Cerebrovasc Dis, 2019, 28:104339.
[21] Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL; American Heart Association Stroke Council. 2018 Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2018, 49:e46-110.
[22] Liu LP, Chen WQ, Duan WY, Huo XC, Xu WH, Li SJ, Li ZX, Huang LA, Wang CX, Zheng HG, Wang YJ. Guidelines for Clinical Management of Cerebrovascular Diseases in China (Excerpt Edition):clinical management of ischemic cerebrovascular disease[J]. Zhongguo Zu Zhong Za Zhi, 2019, 14:709-725.[刘丽萍,陈玮琪,段婉莹,霍晓川,徐蔚海,李淑娟,李子孝,黄立安,王春雪,郑华光,王拥军.中国脑血管病临床管理指南(节选版)——缺血性脑血管病临床管理[J].中国卒中杂志, 2019, 14:709-725.]
[23] Thomalla G, Simonsen CZ, Boutitie F, Andersen G, Berthezene Y, Cheng B, Cheripelli B, Cho TH, Fazekas F, Fiehler J, Ford I, Galinovic I, Gellissen S, Golsari A, Gregori J, Günther M, Guibernau J, Häusler KG, Hennerici M, Kemmling A, Marstrand J, Modrau B, Neeb L, Perez de la Ossa N, Puig J, Ringleb P, Roy P, Scheel E, Schonewille W, Serena J, Sunaert S, Villringer K, Wouters A, Thijs V, Ebinger M, Endres M, Fiebach JB, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Gerloff C; WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset[J]. N Engl J Med, 2018, 379:611-622.
[24] Chinese Stroke Society, Neurointerventional branch of Chinese Stroke Society, Intervention Group of Stroke Prevention and Control Professional Committee, Chinese Preventive Medical Association. Expert consensus on clinical application of tirofiban in atherosclerotic cerebrovascular disease[J]. Zhongguo Zu Zhong Za Zhi, 2019, 14:1034-1044.[中国卒中学会,中国卒中学会神经介入分会,中华预防医学会卒中预防与控制专业委员会介入学组.替罗非班在动脉粥样硬化性脑血管疾病中的临床应用专家共识[J].中国卒中杂志, 2019, 14:1034-1044.]
[25] Suzuki K, Kimura K, Takeuchi M, Morimoto M, Kanazawa R, Kamiya Y, Shigeta K, Ishii N, Takayama Y, Koguchi Y, Takigawa T, Hayakawa M, Ota T, Okubo S, Naito H, Akaji K, Kato N, Inoue M, Hirano T, Miki K, Ueda T, Iguchi Y, Fujimoto S, Otsuka T, Matsumaru Y. The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M 1 occlusion (SKIP study)[J]. Int J Stroke, 2019, 14:752-755.
[26] Yang P, Zhang Y, Zhang L, Zhang Y, Treurniet KM, Chen W, Peng Y, Han H, Wang J, Wang S, Yin C, Liu S, Wang P, Fang Q, Shi H, Yang J, Wen C, Li C, Jiang C, Sun J, Yue X, Lou M, Zhang M, Shu H, Sun D, Liang H, Li T, Guo F, Ke K, Yuan H, Wang G, Yang W, Shi H, Li T, Li Z, Xing P, Zhang P, Zhou Y, Wang H, Xu Y, Huang Q, Wu T, Zhao R, Li Q, Fang Y, Wang L, Lu J, Li Y, Fu J, Zhong X, Wang Y, Wang L, Goyal M, Dippel DWJ, Hong B, Deng B, Roos YBWEM, Majoie CBLM, Liu J; DIRECT-MT Investigators. Endovascular thrombectomy with or without intravenous alteplase in acute stroke[J]. N Engl J Med, 2020, 382:1981-1993.
[27] Dobrocky T, Kaesmacher J, Bellwald S, Piechowiak E, Mosimann PJ, Zibold F, Jung S, Arnold M, Fischer U, Gralla J, Mordasini P. Stent-retriever thrombectomy and rescue treatment of M1 occlusions due to underlying intracranial atherosclerotic stenosis:cohort analysis and review of the literature[J]. Cardiovasc Intervent Radiol, 2019, 42:863-872.
[28] Yu YJ, Xiong W. Tirofiban combined with rt-PA intraarterial thrombolysis improves the recanalization rate of acute middle cerebral artery occlusion in rabbits[J]. Eur Rev Med Pharmacol Sci, 2018, 22:2888-2895.
[29] Feng L, Liu J, Liu Y, Chen J, Su C, Lv C, Wei Y. Tirofiban combined with urokinase selective intra-arterial thrombolysis for the treatment of middle cerebral artery occlusion[J]. Exp Ther Med, 2016, 11:1011-1016.
[30] Shao SJ, Zhang GZ, Zhao L, Huo FR, Ma HB, Zhu L, Yang ZQ, Yin R. Microcatheter infusion of bolus-dose tirofiban for acute ischemic stroke due to distal intracranial artery occlusion[J]. Medicine (Baltimore), 2020, 99:e21366.
[31] Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis[J]. N Engl J Med, 2011, 365:993-1003.
[32] Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A, Gupta R, Kirshner H, Megerian JT, Lesko J, Pitzer P, Ramos J, Castonguay AC, Barnwell S, Smith WS, Gress DR; VISST Trial Investigators. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis:the VISSIT randomized clinical trial[J]. JAMA, 2015, 313:1240-1248.
[33] Chinese Stroke Society, Neurointerventional branch of Chinese Stroke Society. Consensus of Chinese experts on endovascular treatment of symptomatic atherosclerotic non-acute intracranial aortic occlusion[J]. Zhongguo Zu Zhong Za Zhi, 2018, 13:1166-1181.[中国卒中学会,中国卒中学会神经介入分会. 2018症状性动脉粥样硬化性非急性颅内大动脉闭塞血管内治疗中国专家共识[J].中国卒中杂志, 2018, 13:1166-1181.]
[34] Kong Z, Mo Y, Zhang Z, Jiang J. Neurocognitive improvement after angioplasty in patients with chronic middle cerebral artery stenosis and cerebral ischemia[J]. Ann Palliat Med, 2020.[Epub ahead of print]
[35] Gao P, Wang D, Zhao Z, Cai Y, Li T, Shi H, Wu W, He W, Yin L, Huang S, Zhu F, Jiao L, Ji X, Qureshi AI, Ling F. Multicenter prospective trial of stent placement in patients with symptomatic high-grade intracranial stenosis[J]. AJNR Am J Neuroradiol, 2016, 37:1275-1280.
[36] Alexander MJ, Zauner A, Chaloupka JC, Baxter B, Callison RC, Gupta R, Song SS, Yu W; WEAVE Trial Sites and Interventionalists. WEAVE trial:final results in 152 on-label patients[J]. Stroke, 2019, 50:889-894.
[37] Ueda T, Takada T, Nogoshi S, Yoshie T, Takaishi S, Fukano T. Long-term outcome of balloon angioplasty without stenting for symptomatic middle cerebral artery stenosis[J]. J Stroke Cerebrovasc Dis, 2018, 27:1870-1877.
[38] Gruber P, Remonda L. Device profile of different paclitaxel-coated balloons:neuro elutax SV, elutax ‘3’ neuro and SeQuent please NEO for the treatment of symptomatic intracranial high-grade stenosis:overview of their feasibility and safety[J]. Expert Rev Med Devices, 2020, 17:87-92.
[39] EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke:results of an international randomized trial[J]. N Engl J Med, 1985, 313:1191-1200.
[40] Low SW, Teo K, Lwin S, Yeo LL, Paliwal PR, Ahmad A, Sinha AK, Teoh HL, Wong LY, Chong VF, Seet RC, Chan BP, Yeo TT, Chou N, Sharma VK. Improvement in cerebral hemodynamic parameters and outcomes after superficial temporal artery-middle cerebral artery bypass in patients with severe stenoocclusive disease of the intracranial internal carotid or middle cerebral arteries[J]. J Neurosurg, 2015, 123:662-669.
[41] Ning XJ, Gao Q, Chen C, Ling C, Liang JJ, Li ZY, Wang H. Effects of superficial temporal artery-middle cerebral artery bypass on hemodynamics and clinical outcomes in the patients with atherosclerotic stenosis in the intracranial segment of internal carotid artery and middle cerebral artery[J]. Clin Neurol Neurosurg, 2019, 186:105510.

Please choose a citation manager

Content to export